PCWA
ONC icon

Pacific Capital Wealth Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Pacific Capital Wealth Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3
Closed -$674 – 496
2024
Q3 		$674 Buy
+3
New +$540 ﹤0.01% 444

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pacific Capital Wealth Advisors's ONC Position: Q4 2024 in Review

Pacific Capital Wealth Advisors sold out of BeOne Medicines Ltd (ONC) in Q4 2024, closing a stake of 3 shares — an estimated $674 sold.

Pacific Capital Wealth Advisors first reported a position in ONC in Q3 2024 and held it in 1 quarter. The position peaked at $674 in Q3 2024. 229 funds tracked by Wall St. Rank hold ONC as of Q4 2024.

  • Pacific Capital Wealth Advisors reported no remaining BeOne Medicines Ltd position as of Q4 2024 after selling out during the quarter.
  • Pacific Capital Wealth Advisors sold 3 BeOne Medicines Ltd shares in Q4 2024, an estimated $674.
  • Pacific Capital Wealth Advisors first reported a position in BeOne Medicines Ltd in Q3 2024 and held it in 1 quarter.
  • Pacific Capital Wealth Advisors's BeOne Medicines Ltd position peaked at $674 in Q3 2024.
  • 229 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2024.

Based on Pacific Capital Wealth Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.